Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06024928 · ClinicalTrials.gov registry record · NA
Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT06024928 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 23 participants.
The verdict
NCT06024928, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to test the safety and feasibility of using an Automated Insulin Device (AID) in people with Type 2 Diabetes under basal insulin injections to achieve safe and fast basal insulin titration. Participants will be randomized to either the control group or the experimental group. If in the experimental group, the participant will use an insulin pump with Control-IQ Technology (Tandem Diabetes Care) for ten days. Researchers will compare the glycemic control of the experimental group to the control group.
Interventions
- DEVICE Control-IQ use in Type 2 Diabetes under basal insulin injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2025-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06024928
The ClinicalTrials.gov registry entry for NCT06024928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Control-IQ use in Type 2 Diabetes under basal insulin injections is the first listed.
NCT06024928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06024928 about?
NCT06024928 is a clinical study titled "Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes". The purpose of this clinical trial is to test the safety and feasibility of using an Automated Insulin Device (AID) in people with Type 2 Diabetes under basal insulin injections to achieve safe and fast basal insulin titration. Participants will be randomized to either the control group or the exper...
What is the current status of trial NCT06024928?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-06-18. Estimated completion is 2025-12-16.
What interventions are being tested in trial NCT06024928?
The interventions under investigation include: Control-IQ use in Type 2 Diabetes under basal insulin injections (DEVICE).
Who is sponsoring clinical trial NCT06024928?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.